|

Collection of Circulating Biomarkers in Pancreatic Cancer

RECRUITINGSponsored by Abramson Cancer Center at Penn Medicine
Actively Recruiting
SponsorAbramson Cancer Center at Penn Medicine
Started2023-02-27
Est. completion2027-06-30
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT05743049

Summary

This protocol will involve collection of blood samples from patients with a diagnosis of pancreatic adenocarcinoma for evaluation of circulating biomarkers.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* The subject must have a known or presumed diagnosis of pancreatic adenocarcinoma
* The subject must be a patient of the University of Pennsylvania
* The subject must be able to provide informed consent
* The subject must be 18 years of age or older

Exclusion Criteria:

. Subjects who have any clinically significant psychiatric, social, or medical condition that, in the opinion of the investigator, could increase the patient's risk, interfere with protocol adherence, or affect the patient's ability to give informed consent are ineligible to participate in the study.

Conditions2

CancerPancreas Cancer

Locations1 site

Abramson Cancer Center at University of Pennsylvania
Philadelphia, Pennsylvania, 19104

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.